Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Dolan

Showing results (101-110 of 188) with videos related to

Pageof 19
Sort By:
Pharmacogenomics|April 21, 2009
Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell linesShiwei Duan, R Stephanie Huang, Wei Zhang, et al.
Human Molecular Genetics|October 25, 2008
Population-specific GSTM1 copy number variationR Stephanie Huang, Peixian Chen, Steve Wisel, et al.
Human Genetics|December 18, 2008
Identification of genomic regions contributing to etoposide-induced cytotoxicityWasim K Bleibel, Shiwei Duan, R Stephanie Huang, et al.
Investigational New Drugs|January 25, 2008
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemiaOlatoyosi M Odenike, Richard A Larson, Devika Gajria, et al.
American Journal of Human Genetics|November 27, 2010
Population differences in the rate of proliferation of international HapMap cell linesAmy L Stark, Wei Zhang, Tong Zhou, et al.
Pharmacogenetics|October 12, 2004
Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 geneMichael H Wu, Peixian Chen, Xiaolin Wu, et al.
Blood|December 26, 2008
Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicityChristine M Hartford, Shiwei Duan, Shannon M Delaney, et al.
Cancer Research|May 3, 2008
Genetic variants contributing to daunorubicin-induced cytotoxicityR Stephanie Huang, Shiwei Duan, Emily O Kistner, et al.
Molecular Cancer Therapeutics|January 22, 2011
Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivityEric R Gamazon, Hae Kyung Im, Peter H O'Donnell, et al.
Cancer Chemotherapy and Pharmacology|March 8, 2006
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcomaChristopher W Ryan, M Eileen Dolan, Bruce B Brockstein, et al.
Pageof 19

Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
Pharmacogenomics|April 21, 2009
Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell linesShiwei Duan, R Stephanie Huang, Wei Zhang, et al.
Human Molecular Genetics|October 25, 2008
Population-specific GSTM1 copy number variationR Stephanie Huang, Peixian Chen, Steve Wisel, et al.
Human Genetics|December 18, 2008
Identification of genomic regions contributing to etoposide-induced cytotoxicityWasim K Bleibel, Shiwei Duan, R Stephanie Huang, et al.
Investigational New Drugs|January 25, 2008
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemiaOlatoyosi M Odenike, Richard A Larson, Devika Gajria, et al.
American Journal of Human Genetics|November 27, 2010
Population differences in the rate of proliferation of international HapMap cell linesAmy L Stark, Wei Zhang, Tong Zhou, et al.
Pharmacogenetics|October 12, 2004
Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 geneMichael H Wu, Peixian Chen, Xiaolin Wu, et al.
Blood|December 26, 2008
Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicityChristine M Hartford, Shiwei Duan, Shannon M Delaney, et al.
Cancer Research|May 3, 2008
Genetic variants contributing to daunorubicin-induced cytotoxicityR Stephanie Huang, Shiwei Duan, Emily O Kistner, et al.
Molecular Cancer Therapeutics|January 22, 2011
Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivityEric R Gamazon, Hae Kyung Im, Peter H O'Donnell, et al.
Cancer Chemotherapy and Pharmacology|March 8, 2006
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcomaChristopher W Ryan, M Eileen Dolan, Bruce B Brockstein, et al.
Pageof 19